North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management

Ali Alikhan, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, Daniel B Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn Kirby, Michelle A. Lowes, Robert Micheletti, Angela Miller, Haley B. Naik, Dennis Orgill, Yves Poulin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Hidradenitis Suppurativa
Publications
Guidelines
Hair Follicle
Comorbidity
Quality of Life
Delivery of Health Care
Therapeutics

Keywords

  • acne inversa
  • adalimumab
  • biomarkers
  • carbon dioxide laser
  • clindamycin
  • comorbidities
  • ertapenem
  • finasteride
  • guidelines
  • hidradenitis suppurativa
  • infliximab
  • laser
  • lifestyle modification
  • microbiome
  • Nd:YAG
  • oral contraceptive pills
  • rifampin
  • spironolactone

ASJC Scopus subject areas

  • Dermatology

Cite this

North American clinical management guidelines for hidradenitis suppurativa : A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. / Alikhan, Ali; Sayed, Christopher; Alavi, Afsaneh; Alhusayen, Raed; Brassard, Alain; Burkhart, Craig; Crowell, Karen; Eisen, Daniel B; Gottlieb, Alice B.; Hamzavi, Iltefat; Hazen, Paul G.; Jaleel, Tara; Kimball, Alexa B.; Kirby, Joslyn; Lowes, Michelle A.; Micheletti, Robert; Miller, Angela; Naik, Haley B.; Orgill, Dennis; Poulin, Yves.

In: Journal of the American Academy of Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Alikhan, Ali ; Sayed, Christopher ; Alavi, Afsaneh ; Alhusayen, Raed ; Brassard, Alain ; Burkhart, Craig ; Crowell, Karen ; Eisen, Daniel B ; Gottlieb, Alice B. ; Hamzavi, Iltefat ; Hazen, Paul G. ; Jaleel, Tara ; Kimball, Alexa B. ; Kirby, Joslyn ; Lowes, Michelle A. ; Micheletti, Robert ; Miller, Angela ; Naik, Haley B. ; Orgill, Dennis ; Poulin, Yves. / North American clinical management guidelines for hidradenitis suppurativa : A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. In: Journal of the American Academy of Dermatology. 2019.
@article{69ad798e907d4cddb6d9f21fda184fb2,
title = "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management",
abstract = "Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.",
keywords = "acne inversa, adalimumab, biomarkers, carbon dioxide laser, clindamycin, comorbidities, ertapenem, finasteride, guidelines, hidradenitis suppurativa, infliximab, laser, lifestyle modification, microbiome, Nd:YAG, oral contraceptive pills, rifampin, spironolactone",
author = "Ali Alikhan and Christopher Sayed and Afsaneh Alavi and Raed Alhusayen and Alain Brassard and Craig Burkhart and Karen Crowell and Eisen, {Daniel B} and Gottlieb, {Alice B.} and Iltefat Hamzavi and Hazen, {Paul G.} and Tara Jaleel and Kimball, {Alexa B.} and Joslyn Kirby and Lowes, {Michelle A.} and Robert Micheletti and Angela Miller and Naik, {Haley B.} and Dennis Orgill and Yves Poulin",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jaad.2019.02.067",
language = "English (US)",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - North American clinical management guidelines for hidradenitis suppurativa

T2 - A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management

AU - Alikhan, Ali

AU - Sayed, Christopher

AU - Alavi, Afsaneh

AU - Alhusayen, Raed

AU - Brassard, Alain

AU - Burkhart, Craig

AU - Crowell, Karen

AU - Eisen, Daniel B

AU - Gottlieb, Alice B.

AU - Hamzavi, Iltefat

AU - Hazen, Paul G.

AU - Jaleel, Tara

AU - Kimball, Alexa B.

AU - Kirby, Joslyn

AU - Lowes, Michelle A.

AU - Micheletti, Robert

AU - Miller, Angela

AU - Naik, Haley B.

AU - Orgill, Dennis

AU - Poulin, Yves

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.

AB - Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.

KW - acne inversa

KW - adalimumab

KW - biomarkers

KW - carbon dioxide laser

KW - clindamycin

KW - comorbidities

KW - ertapenem

KW - finasteride

KW - guidelines

KW - hidradenitis suppurativa

KW - infliximab

KW - laser

KW - lifestyle modification

KW - microbiome

KW - Nd:YAG

KW - oral contraceptive pills

KW - rifampin

KW - spironolactone

UR - http://www.scopus.com/inward/record.url?scp=85065339304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065339304&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2019.02.067

DO - 10.1016/j.jaad.2019.02.067

M3 - Article

C2 - 30872156

AN - SCOPUS:85065339304

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

ER -